Unaudited Condensed Consolidated Financial Statements

Form: 8-K
Filed: Aug 21, 2024, 4:45 pm ET
Period: Aug 15, 2024
Importance: Major
Accession: 0001213900-24-071491
Document: 8-K
Exhibit 4.1: Assignment, assumption and amendment agreement, dated as of August 15, 2024, by
Exhibit 10.1: Final invoice issued by Earlybirdcapital, Inc. to Moringa Acquisition Corp…
Exhibit 10.1: Convertible promissory note, dated August 15, 2024, in an amount of $1,250,000,
Exhibit 10.2: Subscription agreement, dated August 15, 2024, by and among moringa acquisition
Exhibit 10.3: Ordinary share purchase agreement, dated August 13, 2024 and effective as of…
Exhibit 10.3: Registration rights agreement, dated August 13, 2024 and effective as of the…
Exhibit 10.4: Amended and restated registration rights and lock-up agreement, dated August…
Exhibit 10.5: Amended and restated promissory note, dated August 15, 2024, issued by Silexion
Exhibit 10.6: Form of director and officer indemnification agreement, dated August 15, 2024…
Exhibit 10.12: Silexion Therapeutics Corp 2024 equity incentive plan
Exhibit 99.1: Unaudited condensed consolidated financial statements of Silexion as of June…

Signs a material agreement (1.01)
Completes an acquisition or sale of assets (2.01)
Takes on a new financial obligation (2.03)
Sells unregistered shares (3.02)
Changes shareholder rights (3.03)
Reports a change in control (5.01)
Reports an executive or board change (5.02)
Amends its charter or bylaws (5.03)
Changes its ethics code (5.05)
Changes its shell company status (5.06)
Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.